AzTrials
AzTrials

Pancreatic Solid LesionsNCT03849209

Different Suction Techniques For Endoscopic Ultrasound-Guided Fine-Needle Biopsy In Pancreatic Solid Lesions

A study testing Stylet slow-pull technique and Standard suction technique in people with Pancreatic Solid Lesions, run by ARNAS Civico Di Cristina Benfratelli Hospital at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Ultrasound-guided fine-needle aspiration represents the gold-standard for the pathological diagnosis of solid pancreatic lesions. New needles design allowed to obtain samples suitable for histological evaluation (endoscopic ultrasound-guided fine needle biopsy). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Pancreatic Solid Lesions
What is being tested?
Stylet slow-pull technique and Standard suction technique
Could I receive a placebo?
No, everyone receives an active treatment
How many people
110 participants
Where
1 siteItaly
Study dates
1 May 2017to 31 May 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age >18years old
  • Solid pancreatic lesion on imaging MRI and/or CT-scan referred for tissue acquisition
  • Lesion can be visualized with EUS and needle puncturing can be technically feasible
  • Able to sign informed consent

Who cannot join

  • < 18 years-old
  • Cystic pancreatic lesions
  • Extra-pancreatic lesions or inaccessible/non-visualized lesions
  • Previous gastrectomy
  • International normalized ratio > 1.5
  • Impossibility to suspend anticoagulant therapy
Show all 11Show fewer
  • Platelet count < 50.000 cells/cubic millimeter
  • Severe or unstable clinical conditions
  • Pregnancy
  • Inability to give informed consent
  • Refusal to participate to the study

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • ARNAS Civico - Di Cristina - Benfratelli Hospital

    Palermo, 90127

Other trials in Italy

About this study

Official title: Stylet Slow-Pull Technique Compared To Standard Suction For Endoscopic Ultrasound-Guided Fine-Needle Biopsy In Pancreatic Solid Lesions: Data From A National Multicenter Randomized Trial

Ultrasound-guided fine-needle aspiration represents the gold-standard for the pathological diagnosis of solid pancreatic lesions. New needles design allowed to obtain samples suitable for histological evaluation (endoscopic ultrasound-guided fine needle biopsy). the aim was to compare two different techniques during ultrasound-guided fine needle biopsy, for diagnosis of suspect pancreatic solid lesions.

Read the detailed description

Materials and methods This is a prospective, randomized, multicenter study comparing the slow-pull technique with the standard suction technique during Ultrasound-guided fine-needle biopsy in patients with pancreatic solid lesions. The study involved three referral centers for pancreatico-biliary diseases: the Gastroenterology and Endoscopy Unit. ARNAS Civico-Di Cristina-Benfratelli Hospital, Palermo, Italy; the Gastroenterology and Endoscopy Unit. Marche Polytechnic University, Ospedale A. Murri, Fermo, Italy; the Gastroenterology Unit. AUSL Bologna, Bellaria-Maggiore, Bologna, Italy. The protocol was approved by the institutional medical ethical committee at each participating institution and written informed consent was obtained from all patients for participation in the study. All consecutive patients with a newly diagnosed pancreatic solid lesions suitable for endoscopic ultrasound-guided tissue acquisition were considered for enrollment. Written informed consent was obtained from all patients before the procedure. All the endoscopic ultrasound procedures were carried out by a skilled endosonographer with the patients under conscious sedation or deep sedation according to the anesthesiological guidelines approved in each participating center. All Ultrasound-guided fine-needle biopsy were done using a 20 Gauge needle (EchoTip ProCore 20G with ReCoil Stylet™, Cook Medical, Bloomington, IN, USA). The ReCoil Stylet´s has an automatic recoiling capability designed to help users to manage more easily the stylet, thus minimising the risk of contamination. Before puncturing, color doppler examination was performed to exclude the presence of interposing vessels. The needle tip was sharpened by withdrawing the stylet of approximately 2 mm, and then it was advanced into the lesion under real-time endoscopic ultrasound guidance. In patients randomized to the stylet slow-pull techniques, 15 to-and-fro movements within the lesion were performed while gently pulling the needle stylet slowly and continuously upwards. In patients randomized to the standard suction technique, 15 to-and-fro movements within the lesion were performed using a 10-mL suction syringe. In both sampling procedures the fanning technique was used to maximized sample acquisition. Tissue samples were expelled onto slides by reinserting the stylet and the visible core was physically lifted off the slides placing it into a formalin vial for histological evaluation. For the macroscopic adequacy, the endosonographer evaluated for the presence of a visible core defined as a worm-like material whitish/yellowish or red, not including fluid-like specimens in the formalin vial, which was judged to be adequate to perform a pathological analysis. The pathologists were "blinded" on which group the vials received were belonging to.

Randomization was performed using random sequences generated by a computer and then closed in consecutive numbered envelopes.

The degree of blood contamination of the specimen was based on the pathologist evaluation of the formalin fixed and paraffin embedded tissue samples and defined as significant when a large amount of blood cells made pathological diagnosis difficult to be made. On the other hand, blood contamination of the specimen was defined as not significant when no or only few blood cells were present without any influence on the pathological diagnosis.

Sensitivity was defined as the true positive rate whereby the test was the final cytologic diagnosis, Specificity as the true negative rate (proportion of actual negatives that are correctly identified as such), positive predictive value was defined as the number of true positive divided the number of positive calls (true positive and false positive), negative predictive value was defined as the number of true negative divided the number of negative calls (true negative and false negative). Diagnostic accuracy was defined as the ratio between the sum of true positive and true negative values divided by the total number of masses.

Technical success was defined as the capability of sampling the target lesion associated with the presence of a visible core, according to endosonographer's judgment, potentially useful for the final pathological analysis.

Adverse events were defined based on the criteria expressed by Cotton et al. [Cotton PB. Gastrointest Endosc 2010;71:446-54] Samples positive for malignancy were considered diagnostic for malignancy, while in patients with negative Ultrasound-guided fine-needle biopsy, surgical specimen evaluation, results of other diagnostic investigations and/or a clinical follow-up of at least 6 months were used to establish the definitive diagnosis.

Statistical Analysis The sample size was calculated based on the results of a previous study [Nakai Y H. Dig Dis Sci. 2014;59:1578-85] that showed that blood contamination of the specimen was lower with the stylet slow-pull technique as compared with the standard suction technique (25% vs 70%), with a consequent increase in the diagnostic accuracy. Based on these data we calculated for a difference of 25%, at a power of 80% and an alpha of 0.05 (two-sided test), a final sample size of 110 patients (55 patients in each group). Continuous variables will be reported as mean +/- standard deviation (SD) or as median with interquartile range. Categorical variables will be presented as numbers and percentage and will be compared either using the chi-square test (with Yates' correction when appropriate) or Fisher exact test.

Statistical was conducted using the Fisher's exact test for categorical variables and the Mann-Whitney U-test for continuous variables. Sensitivity, specificity, positive predictive value, negative predictive value, and overall diagnostic accuracy for each arm were investigated by comparing the results with the definitive diagnosis. Statistical tests were considered significant at a corresponding p value of <0.05. Data handling and analyses were done with SPSS 14.

Being tested
Stylet slow-pull technique, Standard suction technique
Keywords
Pancreatic Solid Lesions, Fine-Needle Biopsy, Stylet Slow-Pull Technique, Standard Suction, Endoscopic Ultrasound

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Stylet slow-pull techniqueDevice

    Also called Endoscopic ultrasound-guided fine needle biopsy of pancreas

    During endosonographic examination, the pancreatic mass was evaluated with color Doppler to avoid the involvement of vessels. The needle (20 Gauge, EchoTip ProCore 20G with ReCoil Stylet™, Cook Medical, Bloomington, IN, USA) was sharpened by withdrawing the stylet approximately 2 mm, and then was advanced into the lesion: 15 to-and-fro movements within the lesion were performed, with simultaneous minimal negative pressure provided by pulling the needle stylet slowly and continuously.

  • Standard suction techniqueDevice

    Also called Endoscopic ultrasound-guided fine needle biopsy of pancreas

    During endosonographic examination, the pancreatic mass was evaluated with color Doppler to avoid the involvement of vessels. The needle (20 Gauge, EchoTip ProCore 20G with ReCoil Stylet™, Cook Medical, Bloomington, IN, USA) was sharpened by withdrawing the stylet approximately 2 mm, and then was advanced into the lesion: 15 to-and-fro movements within the lesion were performed using a 10-mL suction syringe.

Study groups in NCT03849209
Study groupRoleWhat they receive
Stylet Slow-Pull Technique groupExperimentalIn patients randomized to the stylet slow-pull techniques an endoscopic ultrasound-guided fine needle biopsy of the pancreatic mass were made with a 20 Gauge needle (EchoTip ProCore 20G with ReCoil Stylet™, Cook Medical, Bloomington, IN, USA): 15 to-and-fro movements within the lesion were performed, with simultaneous minimal negative pressure provided by pulling the needle stylet slowly and continuously.
Receives: Device: Stylet slow-pull technique
Standard Suction Technique groupActive comparatorIn patients randomized to the standard suction technique an endoscopic ultrasound-guided fine needle biopsy of the pancreatic mass were made with a 20 Gauge needle (EchoTip ProCore 20G with ReCoil Stylet™, Cook Medical, Bloomington, IN, USA): 15 to-and-fro movements within the lesion were performed with the use of a 10-mL suction syringe.
Receives: Device: Standard suction technique

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Degree of blood contamination of samples after endoscopic ultrasound-guided fine needle biopsy of pancreatic mass

    Blood contamination of the specimen was considered significant (large amount of blood cells made pathological diagnosis difficult) or not-significant (no/few blood cells without influence on the pathological diagnosis) based on the pathologist evaluation of the formalin fixed and paraffin embedded (FFPE) tissue samples

    Measured: 7 days

  2. Diagnostic accuracy of samples obtained after endoscopic ultrasound-guided fine needle biopsy of pancreatic mass

    Diagnostic accuracy was defined as the ratio between the sum of true positive and true negative values divided by the total number of masses. Sensitivity was defined as the true positive rate whereby the test was the final cytologic diagnosis. Specificity, positive predictive value (PPV), negative predictive value (NPV) were also evaluated.

    Measured: up to 6 months

Secondary outcomes (1)
  1. Technical success of the procedure after endoscopic ultrasound-guided fine needle biopsy of pancreatic mass

    Technical success was defined as the presence of a visible core, according to endosonographer's judgment, potentially useful for the final pathological analysis.

    Measured: 5 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Feb 2019
  2. Study start1 May 2017
  3. Primary completion31 May 2018
  4. Study completion31 May 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
110 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03849209
Sponsor's protocol ID
1270
Status last verified
Feb 2019
First submitted
16 Feb 2019
Last updated
26 Feb 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Stylet slow-pull technique and Standard suction technique in people with Pancreatic Solid Lesions, run by ARNAS Civico Di Cristina Benfratelli Hospital at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Feb 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Degree of blood contamination of samples after endoscopic ultrasound-guided fine needle biopsy of pancreatic mass (time frame: 7 days). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Feb 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in